On March 6, the U.S. Food and Drug Administration approved Istrusia (osilodrostat) oral tablets to treat adult Cushing’s disease patients who cannot undergo pituitary gland surgery or who have had the surgery but still have the disease. Cushing’s disease is a rare disease in which the adrenal glands make too much of the cortisol hormone....
Author: Mark Newman
For residents and early-career clinicians, a lack of sleep is an ongoing health hazard. Endocrine News looks at ways to help you cope with sleep deprivation so you can give your patients the best care possible, as well as take care of your own health. Sleep deprivation has long been a hallmark of medical residents...